Current Hematologic Malignancy Reports Template
Write in a clean editor, then format for Current Hematologic Malignancy Reports in one click — DocuGuru applies the official Springer Nature template with superscript references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.
About the Current Hematologic Malignancy Reports format
Current Hematologic Malignancy Reports is a peer-reviewed journal published by Springer Nature, covering Acute Myeloid Leukemia Research, Lymphoma Diagnosis and Treatment, Chronic Lymphocytic Leukemia Research.
| Publisher | Springer Nature |
|---|---|
| Reference style | Superscript numbered (Nature) Superscript — small raised numerals in the text 1. Smith, A., Jones, B. & Lee, C. A representative article title. Current Hematologic Malignancy Reports 12, 45–58 (2023).
Formats any DOI in Current Hematologic Malignancy Reports style. No sign-up. |
| Publishes research in | Acute Myeloid Leukemia Research Lymphoma Diagnosis and Treatment Chronic Lymphocytic Leukemia Research Chronic Myeloid Leukemia Treatments Acute Lymphoblastic Leukemia research |
| ISSN | 1558-8211 |
| Citation impact (2-yr) | 3.58 |
| h-index | 58 |
| i10-index | 506 |
| Total citations | 17,433 |
| Top institutions publishing here | The University of Texas MD Anderson Cancer Center |
| Journal website | www.springer.com |
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
Papers published in Current Hematologic Malignancy Reports per year
Citation impact of Current Hematologic Malignancy Reports by publication year
Citations each year’s papers have accumulated so far — the most recent years are still building up.
Most-cited papers in Current Hematologic Malignancy Reports
Children with constitutional trisomy 21 (Down syndrome (DS)) have a unique predisposition to develop myeloid leukaemia of Down syndrome (ML-DS). This disorder is preceded by a transient neonatal preleukaemic syndrome, transient abnormal myelopoiesis (TAM). TAM and ML-DS are caused by co-operation between trisomy 21, which itself perturbs fetal haematopoiesis and acquired mutations in the key…